Navdeep S. Dhaliwal

All filings by Navdeep S. Dhaliwal on record concern Supreme Pharmaceuticals Inc. The record holds 8 filings, for trades running from 16 November 2015 to 25 October 2017.

Market trades split into 3 purchases (€29k) and 1 sale (€22k). Taken together, the purchases exceed the sales by €6,924. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 2 option exercises. So far in 2017, the count stands at 2 purchases and no sales.

In size, the median ticket on the buying side is €12k. The 3 purchases reviewed show no overlap with other insiders buying the same stock within a month.

Most recently, on 15 November 2017, the filings show a transaction in Supreme Pharmaceuticals Inc. The last insider purchase was made public on 17 July 2017, 3,386 days ago. Filings reach the SEDI feed a median of 3 days after the trade. Until a filing is published, the market cannot know about the trade. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.